Career Enhancement Program
职业提升计划
基本信息
- 批准号:10480867
- 负责人:
- 金额:$ 8.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-03 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:Acral Lentiginous Malignant MelanomaAddressAwarenessBasal Cell CancerCancer CenterCancer Research ProjectCareer MobilityClinicalCutaneous MelanomaDepartment chairDevelopmentEnsureFacultyFinancial SupportFosteringFoundationsFundingFunding AgencyFutureGoalsGrantInstitutesLaboratoriesLeadershipMeasuresMelanoma CellMentorsMentorshipMinorityMonitorOralOutcomePaperPeer ReviewPennsylvaniaPoliciesPositioning AttributeProceduresProgress ReportsPublicationsPublishingResearchResearch PersonnelResearch Project GrantsResourcesSkin CancerSolidSquamous CellTalentsThe Wistar InstituteTrainingTraining SupportTranslational ResearchUnderrepresented MinorityUniversitiesWomanWorkanticancer researchcancer subtypescareercareer developmentdiversity and inclusionexpectationhealth disparityhigh standardinnovationinterestinvestigator trainingmeetingsmelanomamembernext generationprogramsrecruitresearch and developmentsuccesstranslational cancer researchtranslational research programtranslational scientist
项目摘要
Project Summary – Career Enhancement Program
The goal of the Career Enhancement Program (CEP) is to recruit, train and retain a diverse pool of outstanding
early-career investigators who are committed to pursuing translational skin cancer research. The CEP will be led
by two established investigators with complementary expertise in basic (Dr. Villanueva) and clinical (Dr.
Schuchter) melanoma research. Both co-Directors are committed to training and mentoring of translational
investigators and have an established record of recruiting and supporting women and minorities. The CEP will
primarily assist junior faculty in their career development, but more established investigators interested in
refocusing their research efforts on melanoma/skin cancer could also be considered. Women and
underrepresented minorities will be strongly encouraged to participate. Likewise, projects aimed at addressing
health disparities and/or skin cancer subtypes more common in underrepresented minorities will be encouraged
and given special consideration. A team of clinicians, educators and researchers with broad expertise in
translational research will ensure implementation of the specific aims of this program. With the support of the
University of Pennsylvania, the Abramson Cancer Center and The Wistar Institute, the CEP will provide junior
faculty the resources and guidance needed to establish innovative and fully funded independent skin cancer
research programs and become future academic leaders. The CEP will provide awardees with two years of
financial support for translational research projects in skin cancer with potential promotion to full SPORE projects
or independent grant support. Awardees are required to actively participate in SPORE functions, use the SPORE
Core resources, and provide both formal written progress reports and oral presentations. We have established
high standards and expectations for the research mentors and a formalized program of long-term awardee
mentorship. The program measures success by resulting publications, funding, and ultimately career
advancement and national recognition. We have an outstanding talent pool of candidates and an effective
training and mentorship program that will result in an exceptional group of skin cancer researchers. Our SPORE
CEP has had an outstanding record recruiting and training investigators for careers in translational skin cancer research.
Our past CEP awardees have published 74 papers during the past cycle and have been highly successful in obtaining
peer reviewed funding from NCI and/or other funding agencies. In addition, all past awardees have transitioned from
young investigators into leading academic positions and remain in the skin cancer field.
项目摘要 - 职业增强计划
职业增强计划(CEP)的目标是招募,培训和保留杰出的潜水员库
致力于追求翻译皮肤癌研究的早期研究人员。 CEP将被带领
由两名知名的研究人员在基本(Villanueva博士)和临床方面具有完整的专业知识(博士
Schuchter)黑色素瘤研究。两个联合导演都致力于翻译的培训和心理
调查人员并拥有招募和支持妇女和少数民族的既定记录。 CEP会
初级教职员工的主要协助,但更知名的调查人员对
还可以考虑重新关注黑色素瘤/皮肤癌的研究工作。女人和
代表人数不足的少数民族将被强烈鼓励参加。同样,旨在解决的项目
将鼓励健康分配和/或皮肤癌亚型在代表性不足的少数民族中更为常见
并给予特别考虑。一个临床医生,教育工作者和研究人员,具有广泛的专业知识
翻译研究将确保实施该计划的具体目标。在
宾夕法尼亚大学,艾布拉姆森癌症中心和维斯塔尔研究所,CEP将提供初中
教师建立创新且充分资助的独立皮肤癌所需的资源和指导
研究计划并成为未来的学术领导者。 CEP将为获奖者提供两年
对皮肤癌翻译的研究项目的经济支持,并潜在地推广到全孢子项目
或独立的赠款支持。获奖者必须积极参与孢子功能,使用孢子
核心资源,并提供正式的书面进度报告和口头演示。我们已经建立了
对研究导师的高标准和期望以及长期奖励的正式计划
精神制。该计划通过产生的出版物,资金和最终职业来衡量成功
进步和国家认可。我们拥有出色的候选人人才库,有效
训练和心态计划将导致一群杰出的皮肤癌研究人员。我们的孢子
CEP拥有出色的记录招募和培训研究人员,用于翻译皮肤癌研究的职业。
我们过去的CEP获奖者在过去的周期中发表了74篇论文,并在获得
同行审查了NCI和/或其他资金机构的资金。此外,所有过去的获奖者都从
年轻的研究人员担任领先的学术职位,并留在皮肤癌领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jessie Villanueva其他文献
Jessie Villanueva的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jessie Villanueva', 18)}}的其他基金
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
靶向 S6K2 克服 NRAS 突变黑色素瘤的耐药性
- 批准号:
10539830 - 财政年份:2022
- 资助金额:
$ 8.84万 - 项目类别:
Functional precision approaches to overcome intrinsic and acquired drug resistance in melanoma
克服黑色素瘤内在和获得性耐药性的功能精确方法
- 批准号:
10733196 - 财政年份:2017
- 资助金额:
$ 8.84万 - 项目类别:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
克服 BRAF 和 NRAS-mutan 固有耐药性的分子方法
- 批准号:
8634081 - 财政年份:2013
- 资助金额:
$ 8.84万 - 项目类别:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
克服 BRAF 和 NRAS-mutan 固有耐药性的分子方法
- 批准号:
9054086 - 财政年份:2013
- 资助金额:
$ 8.84万 - 项目类别:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
克服 BRAF 和 NRAS-mutan 固有耐药性的分子方法
- 批准号:
8826711 - 财政年份:2013
- 资助金额:
$ 8.84万 - 项目类别:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
克服 BRAF 和 NRAS-mutan 固有耐药性的分子方法
- 批准号:
9246446 - 财政年份:2013
- 资助金额:
$ 8.84万 - 项目类别:
Molecular approaches to overcome intrinsic drug resistance in BRAF and NRAS-mutan
克服 BRAF 和 NRAS-mutan 固有耐药性的分子方法
- 批准号:
8488046 - 财政年份:2013
- 资助金额:
$ 8.84万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
An Integrated Model of Contextual Safety, Social Safety, and Social Vigilance as Psychosocial Contributors to Cardiovascular Disease
情境安全、社会安全和社会警惕作为心血管疾病社会心理因素的综合模型
- 批准号:
10749134 - 财政年份:2024
- 资助金额:
$ 8.84万 - 项目类别:
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 8.84万 - 项目类别:
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
Implementation Science and Equity: Community Engagement & Outreach (CEO) Core
实施科学与公平:社区参与
- 批准号:
10557511 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别:
Identifying and addressing missingness and bias to enhance discovery from multimodal health data
识别和解决缺失和偏见,以增强多模式健康数据的发现
- 批准号:
10637391 - 财政年份:2023
- 资助金额:
$ 8.84万 - 项目类别: